Manuela Valente 10b5-1 sales reported for SOPH (SOPH)

Rhea-AI Filing Summary

Manuela Valente reported sales of Common Stock under Rule 144 via pre-arranged 10b5-1 transactions. The filing lists multiple dispositions: 01/05/2026 2,085 shares, 01/06/2026 636 shares, 01/20/2026 380 shares, and 02/19/2026 380 shares. The trades show an executing broker Morgan Stanley Smith Barney LLC and reference Restricted Stock Units as the security type.

Insights

Insider Transactions Analyst

Routine, pre-arranged dispositions under a 10b5-1 plan; brokered through Morgan Stanley.

These entries list multiple 10b5-1 sales by Manuela Valente totaling several individual trades on 01/05/2026, 01/06/2026, 01/20/2026, and 02/19/2026. Each row shows the number of shares sold and a dollar figure associated with each trade.

Timing and pricing follow the trade-by-trade detail provided; the filing identifies Morgan Stanley Smith Barney LLC as the executing broker and references Restricted Stock Units as the source of shares. Cash-flow treatment and any post-transaction holdings are not stated in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	380	1865.80	68486338	03/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2026	Restricted Stock Units	Issuer			380	03/18/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	02/19/2026	380	1833.88
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	01/20/2026	380	2040.98
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	01/06/2026	636	3015.72
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	01/05/2026	2085	9603.93

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What transactions did Manuela Valente report on Form 144 for SOPH?

Manuela Valente reported multiple 10b5-1 sales of Common Stock: 2,085 shares on 01/05/2026, 636 on 01/06/2026, and 380 on both 01/20/2026 and 02/19/2026. The filing lists an executing broker.

Which broker executed the reported sales in the Form 144 filing for SOPH?

The trades are shown as executed through Morgan Stanley Smith Barney LLC. The filing text identifies this broker on the securities line but does not disclose net proceeds recipients or post-trade holdings.

What type of securities were sold according to the Form 144 excerpt for SOPH?

The filing references sales of Common Stock originating from Restricted Stock Units. The entries are described as 10b5-1 sales, indicating they were effected under a pre-arranged plan.

Do the Form 144 entries show total proceeds from the sales for SOPH?

Each trade row includes a dollar figure next to the share count, but the filing excerpt does not present an aggregate proceeds total. The entries list amounts per trade without summing them.

Does the filing state how many shares Valente holds after these sales?

The provided excerpt does not state post-transaction holdings or total shares outstanding. The listing focuses on individual 10b5-1 sales and associated broker information.